Literature DB >> 10981063

Role of nitric oxide in the control of renal function and salt sensitivity.

A P Zou1, A W Cowley.   

Abstract

Nitric oxide (NO) plays critical roles in the control of renal and glomerular hemodynamics, tubuloglomerular feedback response, release of renin and sympathetic transmitters, tubular ion transport, and renal water and sodium excretion. This paper explores the importance of NO in the control of renal water and sodium excretion and in the long-term control of arterial blood pressure. Synthesis of NO, characteristics of NO tissue redox forms, NO synthase activity, and NO synthase isoforms in the kidney are reviewed. To define the role of NO as a natriuretic and antihypertensive factor, the most supportive evidence is summarized, and some contradictory results are also noted. Given the evidence that high salt intake results in high NO concentrations and great NO synthase expression and activity selectively in the renal medulla of the kidney, as well as evidence of a deficiency of the NO synthase activity in Dahl salt-sensitive rats confined in the renal medulla, this report emphasizes the mechanisms by which the renal medullary l-arginine/NO system controls sodium excretion and arterial blood pressure. Other mechanisms for the action of NO on sodium homeostasis such as the action on glomerular filtration rate and the direct effect on tubules are also discussed. We conclude that there is strong evidence that under physiologic conditions, NO plays an important role in the regulation of renal blood flow to the renal medulla and in the tubular regulation of sodium excretion. It is thereby involved in the long-term control of arterial blood pressure, and inhibition or deficiency of NO synthase may result in a sustained hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10981063     DOI: 10.1007/s11906-999-0016-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  55 in total

1.  Nitric oxide synthase in macula densa regulates glomerular capillary pressure.

Authors:  C S Wilcox; W J Welch; F Murad; S S Gross; G Taylor; R Levi; H H Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 2.  Regulation of expression of the endothelial cell nitric oxide synthase.

Authors:  D G Harrison; H Sayegh; Y Ohara; N Inoue; R C Venema
Journal:  Clin Exp Pharmacol Physiol       Date:  1996-03       Impact factor: 2.557

3.  Role of nitric oxide in renal papillary blood flow and sodium excretion.

Authors:  D L Mattson; R J Roman; A W Cowley
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

Review 4.  Nitric oxide: pathophysiological mechanisms.

Authors:  S S Gross; M S Wolin
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

Review 5.  Biosynthesis and homeostatic roles of nitric oxide in the normal kidney.

Authors:  B C Kone; C Baylis
Journal:  Am J Physiol       Date:  1997-05

6.  Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage.

Authors:  C Baylis; B Mitruka; A Deng
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation.

Authors:  J Hoffend; A Cavarape; K Endlich; M Steinhausen
Journal:  Am J Physiol       Date:  1993-08

8.  Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotension II.

Authors:  C Baylis; J Harvey; K Engels
Journal:  J Am Soc Nephrol       Date:  1994-08       Impact factor: 10.121

9.  Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide.

Authors:  P J Shultz; J P Tolins
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats.

Authors:  A Patel; S Layne; D Watts; K A Kirchner
Journal:  Hypertension       Date:  1993-12       Impact factor: 10.190

View more
  25 in total

Review 1.  The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system.

Authors:  Crystal A West; Jennifer M Sasser; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-05

Review 2.  Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.

Authors:  Arvind K Pandey; Eric K Singhi; Juan Pablo Arroyo; Talat Alp Ikizler; Edward R Gould; Jonathan Brown; Joshua A Beckman; David G Harrison; Javid Moslehi
Journal:  Hypertension       Date:  2017-12-26       Impact factor: 10.190

3.  Nitric oxide production by glomerular podocytes.

Authors:  Oleg Palygin; Daria V Ilatovskaya; Vladislav Levchenko; Bradley T Endres; Aron M Geurts; Alexander Staruschenko
Journal:  Nitric Oxide       Date:  2017-11-08       Impact factor: 4.427

Review 4.  Renal Toxicities of Targeted Therapies.

Authors:  Anum Abbas; Mohsin M Mirza; Apar Kishor Ganti; Ketki Tendulkar
Journal:  Target Oncol       Date:  2015-12       Impact factor: 4.493

5.  Hypoxia inducible factor-1α-mediated gene activation in the regulation of renal medullary function and salt sensitivity of blood pressure.

Authors:  Ningjun Li
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

Review 6.  Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker.

Authors:  Emily S Robinson; Eliyahu V Khankin; S Ananth Karumanchi; Benjamin D Humphreys
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

Review 7.  VEGF inhibition, hypertension, and renal toxicity.

Authors:  Suzanne R Hayman; Nelson Leung; Joseph P Grande; Vesna D Garovic
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

8.  TRPV4 activation mediates flow-induced nitric oxide production in the rat thick ascending limb.

Authors:  Pablo D Cabral; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

9.  Salt-sensitive hypertension induced by decoy of transcription factor hypoxia-inducible factor-1alpha in the renal medulla.

Authors:  Ningjun Li; Li Chen; Fan Yi; Min Xia; Pin-Lan Li
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

Review 10.  Bevacizumab-induced hypertension: Clinical presentation and molecular understanding.

Authors:  Megan Li; Deanna L Kroetz
Journal:  Pharmacol Ther       Date:  2017-09-04       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.